Follikuláris limfóma: vizsgálatok itt: Finnország
5 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
- Where
- Helsinki, Kuopio, Tampere
- Életkor
- 18 év to 130 év
- People
- 1018 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06549595 · EU 2023-510098-33-01 - 2. fázisTaking peoplePrimary treatment of follicular lymphoma with rituximab-lenalidomide-tafasitamab for high-risk disease and rituximab-lenalidomide with a 1:1 randomization to tafasitamab for low-risk disease: a phase II study – NLG-FL7
- Where
- Helsinki, Kuopio, Oulu, Tampere, Turku
- Életkor
- 18 év and over
- People
- 270 worldwide
- Run by
- Karolinska University Hospital
See details and how to join2023-508196-36-00 · EU 2023-508196-36-00 - 2. fázisTaking peopleEfficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
- Where
- Helsinki, Oulu, Turku
- Életkor
- 18 év to 70 év
- People
- 213 worldwide
- Run by
- Miltenyi Biomedicine GmbH
See details and how to joinNCT04844866 · EU 2023-506270-13-00 - 3. fázisTaking peopleA Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
- Where
- Helsinki, Oulu, Turku
- Életkor
- 18 év and over
- People
- 400 worldwide
- Run by
- Celgene
See details and how to joinNCT06911502 · EU 2024-519152-82-00 - 2. fázisTaking peopleMosunetuzumab for Early Relapse of Follicular Lymphoma in the Nordic Countries
- Where
- Helsinki
- Életkor
- 18 év and over
- People
- 80 worldwide
- Run by
- Oslo University Hospital
See details and how to joinNCT05849857